Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.2%

5 terminated out of 97 trials

Success Rate

88.6%

+2.1% vs benchmark

Late-Stage Pipeline

8%

8 trials in Phase 3/4

Results Transparency

13%

5 of 39 completed with results

Key Signals

5 with results89% success

Data Visualizations

Phase Distribution

73Total
Not Applicable (55)
Early P 1 (1)
P 1 (1)
P 2 (8)
P 3 (6)
P 4 (2)

Trial Status

Completed39
Unknown23
Recruiting16
Active Not Recruiting7
Terminated5
Not Yet Recruiting4

Trial Success Rate

88.6%

Benchmark: 86.5%

Based on 39 completed trials

Clinical Trials (97)

Showing 20 of 20 trials
NCT07570368Not ApplicableNot Yet Recruiting

Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer

NCT07387445Not ApplicableRecruiting

Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.

NCT07527468Not ApplicableNot Yet Recruiting

HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery

NCT05417516Phase 3RecruitingPrimary

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

NCT03650894Phase 2Active Not RecruitingPrimary

Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients

NCT07465523RecruitingPrimary

A Novel Approach in the Evaluation of Breast Masses With Doppler US

NCT05700006CompletedPrimary

Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging

NCT06187909Not ApplicableCompletedPrimary

PECS II vs. MTP for Analgesia After MRM

NCT03096418Phase 4RecruitingPrimary

Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response

NCT04113863Phase 2TerminatedPrimary

Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer

NCT06711523Phase 3Active Not Recruiting

Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy

NCT03524430Not ApplicableRecruitingPrimary

RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy

NCT04343807Not ApplicableCompletedPrimary

Effectiveness of Ultrasound Guided PECS Block on Opioid Consumption and Patient Satisfaction Through Adequate Pain Control Following Breast Cancer Surgery.

NCT06892275Not ApplicableRecruitingPrimary

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

NCT03425838Phase 3Active Not RecruitingPrimary

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

NCT07180433Not ApplicableNot Yet RecruitingPrimary

Piloting 18F-FAPI PET/MRI for Applications in Breast Cancer

NCT04812652Not ApplicableActive Not RecruitingPrimary

Digitally Distributed Yoga for Women Treated for Breast Cancer

NCT04815083Phase 3TerminatedPrimary

Fluorescence Imaging of Carcinoma During Breast Conserving Surgery

NCT06412107Not ApplicableCompletedPrimary

Somatic Acupressure for Symptom Cluster Management in Breast Cancer Survivors

NCT03323346Phase 2RecruitingPrimary

Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer

Scroll to load more

Research Network

Activity Timeline